EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.

Cancer letters

Volumn 262, Issue 1, 2008, Pages 10-18

  Shimizu, Masahito ^a   Shirakami, Yohei ^b   Sakai, Hiroyasu ^b   Tatebe, Hideharu ^b   Nakagawa, Takayuki ^b   Hara, Yukihiko ^b   Weinstein, I Bernard ^b   Moriwaki, Hisataka ^b  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL PROLIFERATION; DRUG EFFECT; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 79960691382     PISSN: None     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.026     Document Type: Article

References (0)